Visual field defects of optic neuritis in neuromyelitis optica compared with multiple sclerosis

BMC Neurology

Volumn 10, Issue , 2010, Pages

  Nakajima, Hideto ^a,b   Hosokawa, Takafumi ^a   Sugino, Masakazu ^a   Kimura, Fumiharu ^a   Sugasawa, Jun ^a   Hanafusa, Toshiaki ^a   Takahashi, Toshiyuki ^c  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b Seikeikai Hospital   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CENTRAL SCOTOMA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HEMIANOPIA; HUMAN; MALE; MEDICAL RECORD REVIEW; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NEUROLOGIC EXAMINATION; OPTIC NEURITIS; RELAPSE; VISUAL FIELD; VISUAL FIELD DEFECT; COMPARATIVE STUDY; DISEASE COURSE; INCIDENCE; PATHOLOGY; RECURRENT DISEASE; RETROSPECTIVE STUDY; SCOTOMA; VISUAL DISORDER;

ADULT; DISEASE PROGRESSION; FEMALE; HEMIANOPSIA; HUMANS; INCIDENCE; MALE; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA; OPTIC NEURITIS; RECURRENCE; RETROSPECTIVE STUDIES; SCOTOMA; VISION DISORDERS;

EID: 77953648134     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-10-45     Document Type: Article

References (33)

1. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurol 2007, 6:805-815. 10.1016/S1474-4422(07)70216-8, 17706564.
2. Pittock SJ. Neuromyelitis optica: A new perspective. Seminars in neurology 2008, 1:95-104.
3. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999, 53:1107-1114.
4. Papeix C, Vidal JS, de Seze J, Pierrot-Deseilligny C, Tourbah A, Stankoff B, Lebrun C, Moreau T, Vermersch P, Fontaine B, Lyon-Caen O, Gout O. Immunosuppressive therapy is more effective than interferon in neuromyelitis optica. Mult Scler 2007, 13:256-259. 10.1177/1352458506070732, 17439893.
5. Watanabe S, Misu T, Miyazawa I, Nakashima I, Shiga Y, Fujihara K, Itoyama Y. Low-dose corticosteroids reduce relapses in neuromyelitis optica: a retrospective analysis. Mult Scler 2007, 13:968-974. 10.1177/1352458507077189, 17623727.
6. Watanabe S, Nakashima I, Misu T, Miyazawa I, Shiga Y, Fujihara K, Itoyama Y. Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica. Mult Scler 2007, 13:128-132. 10.1177/1352458506071174, 17294622.
7. Cree BA, Lamb S, Morgan K, Chen A, Waubant E, Genain C. An open label study of the effects of rituximab in neuromyelitis optica. Neurology 2005, 64:1270-1272.
8. Jacob A, Weinshenker BG, Violich I, McLinskey N, Krupp L, Fox RJ, Wingerchuk DM, Boggild M, Constantinescu CS, Miller A, De Angelis T, Matiello M, Cree BA. Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients. Arch Neurol 2008, 65:1443-1448. 10.1001/archneur.65.11.noc80069, 18779415.
9. Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, Trebst C, Weinshenker B, Wingerchuk D, Parisi JE, Lassmann H. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2002, 125:1450-1461. 10.1093/brain/awf151, 12076996.
10. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004, 364:2106-2112. 10.1016/S0140-6736(04)17551-X, 15589308.
11. Jarius S, Aboul-Enein F, Waters P, Kuenz B, Hauser A, Berger T, Lang W, Reindl M, Vincent A, Kristoferitsch W. Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain 2008, 131:3072-3080. 10.1093/brain/awn240, 2577801, 18945724.
12. Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, Nakamura M, Watanabe S, Shiga Y, Kanaoka C, Fujimori J, Sato S, Itoyama Y. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain 2007, 130:1235-1243. 10.1093/brain/awm062, 17449477.
13. Matsuoka T, Matsushita T, Kawano Y, Osoegawa M, Ochi H, Ishizu T, Minohara M, Kikuchi H, Mihara F, Ohyagi Y, Kira J. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain 2007, 130:1206-1223. 10.1093/brain/awm027, 17439988.
14. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006, 66:1485-1489. 10.1212/01.wnl.0000216139.44259.74, 16717206.
15. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001, 50:121-127. 10.1002/ana.1032, 11456302.
16. Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, Nakamura M, Watanabe S, Ishii N, Itoyama Y. Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica. Tohoku J Exp Med 2006, 210:307-313. 10.1620/tjem.210.307, 17146196.
17. Warner J, Lessell S. Neuro-ophthalmology of multiple sclerosis. Clin Neurosci 1994, 2:180-188.
18. Merle H, Olindo S, Bonnan M, Donnio A, Richer R, Smadja D, Cabre P. Natural history of the visual impairment of relapsing neuromyelitis optica. Ophthalmology 2007, 114:810-815. 10.1016/j.ophtha.2006.06.060, 17141316.
19. Naismith RT, Tutlam NT, Xu J, Klawiter EC, Shepherd J, Trinkaus K, Song SK, Cross AH. Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis. Neurology 2009, 72:1077-1082. 10.1212/01.wnl.0000345042.53843.d5, 2677471, 19307541.
20. Mandler RN, Davis LE, Jeffery DR, Kornfeld M. Devic's neuromyelitis optica: a clinicopathological study of 8 patients. Ann Neurol 1993, 34:162-168. 10.1002/ana.410340211, 8338340.
21. Lucchinetti CF, Parisi J, Bruck W. The pathology of multiple sclerosis. Neurol Clin 2005, 23:77-105. 10.1016/j.ncl.2004.09.002, 15661089.
22. Misu T, Fujihara K, Kakita A, Konno H, Nakamura M, Watanabe S, Takahashi T, Nakashima I, Takahashi H, Itoyama Y. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 2007, 130:1224-1234. 10.1093/brain/awm047, 17405762.
23. Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 2007, 130:1194-1205. 10.1093/brain/awl371, 17282996.
24. Nagelhus EA, Veruki ML, Torp R, Haug FM, Laake JH, Nielsen S, Agre P, Ottersen OP. Aquaporin-4 water channel protein in the rat retina and optic nerve: polarized expression in Müller cells and fibrous astrocytes. J Neurosci 1998, 18:2506-2519.
25. Guy J, Rao NA. Acute and chronic experimental optic neuritis. Alteration in the blood-optic nerve barrier. Arch Ophthalmol 1984, 102:450-454.
26. Hofman P, Hoyng P, vanderWerf F, Vrensen GF, Schlingemann RO. Lack of blood-brain barrier properties in microvessels of the prelaminar optic nerve head. Invest Ophthalmol Vis Sci 2001, 42:895-901.
27. Graber DJ, Levy M, Kerr D, Wade WF. Neuromyelitis optica pathogenesis and aquaporin 4. J Neuroinflammation 2008, 5:22. 10.1186/1742-2094-5-22, 2427020, 18510734.
28. Gerling J, Meyer JH, Kommerell G. Visual field defects in optic neuritis and anterior ischemic optic neuropathy: distinctive features. Graefes Arch Clin Exp Ophthalmol 1998, 236:188-192. 10.1007/s004170050062, 9541821.
29. Levin LA, Rizzo JF, Lessell S. Neural network differentiation of optic neuritis and anterior ischaemic optic neuropathy. Br J Ophthalmol 1996, 80:835-839. 10.1136/bjo.80.9.835, 505623, 8942383.
30. Green AJ, Cree BAC. Distinctive retinal nerve fibre layer and vascular changes in neuromyelitis optica following optic neuritis. J Neurol Neurosurg Psychiatry 2009, 80:1002-1005. 10.1136/jnnp.2008.166207, 19465415.
31. Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 2007, 130:1194-1205. 10.1093/brain/awl371, 17282996.
32. Pirko I, Blauwet LK, Lesnick TG, Weinshenker BG. The natural history of recurrent optic neuritis. Arch Neurol 2004, 61:1401-1405. 10.1001/archneur.61.9.1401, 15364686.
33. Matiello M, Lennon VA, Jacob A, Pittock SJ, Lucchinetti CF, Wingerchuk DM, Weinshenker BG. NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology 2008, 70:2197-2200. 10.1212/01.wnl.0000303817.82134.da, 18434643.